Inflammatix Inc

Summary

Inflammatix Inc (Inflammatix) is a molecular diagnostics company developing host response-based diagnostic tests that read the immune system to resolve major clinical and public health challenges. Inflammatix's HostDx Sepsis test is used to identify or diagnose acute infections and sepsis in ED or urgent care clinic; traumatic injuries; neonate and ICU patient monitoring scenarios; and HostDx Fever test is used to diagnose bacterial infection in outpatient clinics and urgent care centers. The company is focused on developing tests for acute bacterial and viral infections, sepsis, tropical infections, autoimmune diseases, and transplant rejection based on patent-pending biomarkers licensed from Stanford University. Inflammatix is headquartered in Burlingame, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Inflammatix Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Inflammatix Inc Company Overview
Inflammatix Inc Company Snapshot
Inflammatix Inc Pipeline Products and Ongoing Clinical Trials Overview
Inflammatix Inc – Pipeline Analysis Overview
Inflammatix Inc - Key Facts
Inflammatix Inc - Major Products and Services
Inflammatix Inc Pipeline Products by Development Stage
Inflammatix Inc Ongoing Clinical Trials by Trial Status
Inflammatix Inc Pipeline Products Overview
Diagnostic Test - Acute Solid-Organ Transplant Rejection
Diagnostic Test - Acute Solid-Organ Transplant Rejection Product Overview
Diagnostic Test - Dengue
Diagnostic Test - Dengue Product Overview
HostDx Fever
HostDx Fever Product Overview
HostDx Sepsis
HostDx Sepsis Product Overview
HostDx Sepsis Clinical Trial
HostDxENDOTYPES
HostDxENDOTYPES Product Overview
HostDxFEVERFLU
HostDxFEVERFLU Product Overview
HostDxTNFresponse
HostDxTNFresponse Product Overview
HostDxTROPICALFEVER
HostDxTROPICALFEVER Product Overview
Inflammatix Inc - Key Competitors
Inflammatix Inc - Key Employees
Inflammatix Inc - Locations And Subsidiaries
Head Office
Recent Developments
Inflammatix Inc, Recent Developments
Mar 04, 2020: New Inflammatix study in nature communications outlines breakthrough in diagnosing acute infections by reading the immune system
Oct 07, 2019: Inflammatix: Chief technology officer
May 16, 2019: Inflammatix named a finalist for AACC's Disruptive Technology Award for its rapid HostDx Tests
Oct 04, 2018: Inflammatix to present new data at IDWeek 2018 demonstrating ability to perform HostDx Fever Test to rapidly distinguish bacterial from viral infections across multiple laboratory platforms
Apr 10, 2018: Inflammatix Named a Finalist in Fast Company''s 2018 World Changing Ideas Awards for Its Novel HostDx Tests
Feb 15, 2018: New Study Published in 'Nature Communications' Suggests Sepsis Can Be Detected By Measuring the Immune System
Jan 17, 2018: Inflammatix Immune Response Tests Could Enable Antibiotic Decisions in One Hour
Dec 19, 2017: Inflammatix Announces Appointment of Oliver Liesenfeld, M.D., as Chief Medical Officer
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Inflammatix Inc Pipeline Products and Ongoing Clinical Trials Overview
Inflammatix Inc Pipeline Products by Equipment Type
Inflammatix Inc Pipeline Products by Indication
Inflammatix Inc Ongoing Clinical Trials by Trial Status
Inflammatix Inc, Key Facts
Inflammatix Inc, Major Products and Services
Inflammatix Inc Number of Pipeline Products by Development Stage
Inflammatix Inc Pipeline Products Summary by Development Stage
Inflammatix Inc Ongoing Clinical Trials by Trial Status
Inflammatix Inc Ongoing Clinical Trials Summary
Diagnostic Test - Acute Solid-Organ Transplant Rejection - Product Status
Diagnostic Test - Acute Solid-Organ Transplant Rejection - Product Description
Diagnostic Test - Dengue - Product Status
Diagnostic Test - Dengue - Product Description
HostDx Fever - Product Status
HostDx Fever - Product Description
HostDx Sepsis - Product Status
HostDx Sepsis - Product Description
HostDx Sepsis - Clinical Validation of HostDx Sepsis on NanoString; A Prospective Observational Validation Trial
HostDx Sepsis - HostDx Sepsis in the Diagnosis and Prognosis of Emergency Department Patients with Suspected Infections and Suspected Sepsis
HostDxENDOTYPES - Product Status
HostDxENDOTYPES - Product Description
HostDxFEVERFLU - Product Status
HostDxFEVERFLU - Product Description
HostDxTNFresponse - Product Status
HostDxTNFresponse - Product Description
HostDxTROPICALFEVER - Product Status
HostDxTROPICALFEVER - Product Description
Inflammatix Inc, Key Employees
Glossary
List of Figures
Inflammatix Inc Pipeline Products by Equipment Type
Inflammatix Inc Pipeline Products by Development Stage
Inflammatix Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook